Applied BioCode, Diatherix Ink Partnership
News Jun 17, 2016
Diatherix Laboratories will utilize Applied BioCode's Barcoded Magnetic Beads and BioCode detection systems in conjunction with their proprietary TEM-PCR™ technology to develop highly sensitive multiplex molecular diagnostic infectious disease panels for their laboratory customers.
"We are very pleased to partner with Diatherix Laboratories in this important area of the market," said Winston Ho, President of Applied BioCode. "Our Barcoded Magnetic Beads combined with the Diatherix TEM-PCR™ technology will provide an elegant solution for multiplexing of molecular diagnostic infectious disease tests. We embrace their ability to quickly identify co-infections and link diagnostics testing to the right therapeutic to significantly improve patient outcomes and reduce overall healthcare costs."
"We are pleased to partner with Applied BioCode for their Barcoded Magnetic Bead technology," said Dennis Grimaud, CEO of Diatherix Laboratories. "Their Barcoded Magnetic Bead technology will allow us to reduce the development timeframe to bring new multiplex test panels to market and enhance the sensitivity of our molecular diagnostic panels. We look forward to a long and successful partnership with Applied BioCode."
In a new study in cells, University of Illinois researchers have adapted CRISPR gene-editing technology to cause the cell’s internal machinery to skip over a small portion of a gene when transcribing it into a template for protein building. This gives researchers a way not only to eliminate a mutated gene sequence, but to influence how the gene is expressed and regulated.